SEQUENT.NS

Sequent Scientific Limited [SEQUENT.NS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

SEQUENT.NS Stock Summary

The Moving Average Convergence Divergence (MACD) for SEQUENT.NS recently turned positive (within last 10 days).

Top 10 Correlated Stocks

SEQUENT.NS

In the News

SEQUENT.NS Financial details

Company Rating

Market Cap

30.81B

Income

-1.29B

Revenue

13.75B

Book val./share

Cash/share

Dividend

Dividend %

Employees

1.3K

Optionable

Shortable

Yes

Earnings

21 May 2024

P/E

-23.22

Forward P/E

PEG

0.57

P/S

2.23

P/B

5.36

P/C

P/FCF

191.7

Quick Ratio

0.65

Current Ratio

1.28

Debt / Equity

LT Debt / Equity

EPS (TTM)

-5.18

EPS next Y

EPS next Q

EPS this Y

-392.22%

EPS next Y

EPS next 5Y

EPS last 5Y

NAN%

Revenue last 5Y

6.84%

Revenue Q/Q

-4.8%

EPS Q/Q

-197.06%

SMA20

6.7%

SMA50

-6.94%

SMA100

-26.51%

Inst Own

Inst Trans

ROA

-10%

ROE

-20%

ROC

-0.06%

Gross Margin

42%

Oper. Margin

-4%

Profit Margin

-10%

Payout

Shs Outstand

Shs Float

Target Price

52W Range

69.8-155.5

52W High

-7.03%

52W Low

+108.84%

RSI

49.61

Rel Volume

0.18

Avg Volume

1.88M

Volume

345.45K

Perf Week

-2.75%

Perf Month

1.96%

Perf Quarter

-24.73%

Perf Half Y

-12.75%

Beta

0.507

Volatility

2.91%, 6.8%

Prev Close

-2.23%

Price

144.1

Change

-3.93%

Something similar

Top by Market Cap

Same Sector

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 1.88M
Market Capitalization 30.81B
Employee 1.3K
CEO Mr. Rajaram Narayanan
Headquarters Mumbai,IN
IPO Date 2016-03-10
Website https://www.sequent.in

Sequent Scientific Limited engages in the animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) and finished dosage formulations in the areas of feed supplements, antibiotics, anthelmintics, antibacterial, anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It offers analytical solutions that supports API, pharmaceutical, personal care, and nutraceutical organizations, as well as provides method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to Sequent Scientific Limited in October 2009. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited operates as a subsidiary of CA Harbor Investments.